Alzheimer's model mice fare worse in strength tests at middle age
An experiment in male mice found poorer strength-test performance in middle-aged Alzheimer's model mice than controls, despite preserved muscle size and general motor performance.

Our read
Mechanisms- Studied:
- Preprint: experiments in adult and middle-aged male mice, against age-matched wild-type mice
- What changed:
- Middle-aged Alzheimer's model mice performed worse on strength tests than age-matched wild-type mice
- The catch:
- The experiment did not separate muscle and spinal cord contributions to poorer strength-test performance
- In the record:
- One of 3,055 papers on APP on record: 13 with results in people, 114 in animals.
Editor of record: Boris Djordjevic · AgingResearch.News
Adult and middle-aged male mice engineered to model Alzheimer's disease were compared with age-matched mice without those genetic changes in an animal experiment. Middle-aged model mice performed worse on strength-related tests; adult model mice did not. Muscle mass, muscle fiber size and general motor performance were preserved.
Muscle also showed structural changes and altered molecular profiles related to muscle development. Despite evident brain pathology involving amyloid-beta, a protein associated with Alzheimer's disease, muscle showed no apparent staining for it. The model mice had greater amyloid-beta deposition in the lower spinal cord, alongside other pathological changes. The authors concluded that Alzheimer's-related physical dysfunction may involve abnormalities in both skeletal muscle and the spinal system that controls movement.
Why it matters
Muscle dysfunction in Alzheimer's disease raises questions about how this age-related disease affects movement beyond the brain.
Caveats
The accompanying muscle and spinal cord abnormalities do not identify which contributed to poorer strength-test performance. The experiment involved male mice in one Alzheimer's model, and the preprint has not yet been peer-reviewed.
The paper
Fujita Health University School of Medicine; Nagoya University Graduate School of Medicine
bioRxiv, Nov 17, 2026, Open access, CC BY-NC-ND, Preprint, not yet peer-reviewed

Comments
Be the first to comment.